Literature DB >> 12559182

Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis.

Sakhawat H Rahman1, Basil J Ammori1, John Holmfield1, Michael Larvin2, Michael J McMahon1.   

Abstract

Intestinal barrier failure and subsequent bacterial translocation have been implicated in the development of organ dysfunction and septic complications associated with severe acute pancreatitis. Splanchnic hypoperfusion and ischemia/reperfusion injury have been postulated as a cause of increased intestinal permeability. The urinary concentration of intestinal fatty acid binding protein (IFABP) has been shown to be a sensitive marker of intestinal ischemia, with increased levels being associated with ischemia/reperfusion. The aim of the current study was to assess the relationship between excretion of IFABP in urine, gut mucosal barrier failure (intestinal hyperpermeability and systemic exposure to endotoxemia), and clinical severity. Patients with a clinical and biochemical diagnosis of acute pancreatitis were studied within 72 hours of onset of pain. Polyethylene glycol probes of 3350 kDa and 400 kDa were administered enterally, and the ratio of the percentage of retrieval of each probe after renal excretion was used as a measure of intestinal macromolecular permeability. Collected urine was also used to determine the IFABP concentration (IFABP-c) and total IFABP (IFABP-t) excreted over the 24-hour period, using an enzyme-linked immunosorbent assay technique. The systemic inflammatory response was estimated from peak 0 to 72-hour plasma C-reactive protein levels, and systemic exposure to endotoxins was measured using serum IgM endotoxin cytoplasmic antibody (EndoCAb) levels. The severity of the attack was assessed on the basis of the Atlanta criteria. Sixty-one patients with acute pancreatitis (severe in 19) and 12 healthy control subjects were studied. Compared to mild attacks, severe attacks were associated with significantly higher urinary IFABP-c (median 1092 pg/ml vs. 84 pg/ml; P < 0.001) and IFABP-t (median 1.14 microg vs. 0.21 microg; P = 0.003). Furthermore, the control group had significantly lower IFABP-c (median 37 pg/ml; P = 0.029) and IFABP-t (median 0.06 microg; P = 0.005) than patients with mild attacks. IFABP correlated positively with the polyethylene glycol 3350 percentage retrieval (r = 0.50; P < 0.001), CRP (r = 0.51; P < 0.001), and inversely with serum IgM EndoCAb levels (r = -0.32; P = 0.02). The results of this study support the hypothesis that splanchnic hypoperfusion contributes to the loss of intestinal mucosal integrity associated with a severe attack of pancreatitis. Copyright 2003 The Society for Surgery of the Alimentary Tract, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559182     DOI: 10.1016/S1091-255X(02)00090-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  91 in total

1.  The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU.

Authors:  J R Border; J Hassett; J LaDuca; R Seibel; S Steinberg; B Mills; P Losi; D Border
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

2.  Potentiation by endotoxin of responses associated with increases in calcium conductance.

Authors:  J Connor; J Fine; K Kusano; J McCrea; I Parnas; C L Prosser
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

Review 3.  Bacterial endotoxins and host immune responses.

Authors:  D C Morrison; J L Ryan
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

Review 4.  Secondary organ dysfunction. From clinical perspectives to molecular mediators.

Authors:  M D Cipolle; M D Pasquale; F B Cerra
Journal:  Crit Care Clin       Date:  1993-04       Impact factor: 3.598

5.  Postburn gastrointestinal vasoconstriction increases bacterial and endotoxin translocation.

Authors:  R Tokyay; S T Zeigler; D L Traber; J C Stothert; H M Loick; J P Heggers; D N Herndon
Journal:  J Appl Physiol (1985)       Date:  1993-04

6.  Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis.

Authors:  E J Luiten; W C Hop; J F Lange; H A Bruining
Journal:  Ann Surg       Date:  1995-07       Impact factor: 12.969

7.  APACHE-acute physiology and chronic health evaluation: a physiologically based classification system.

Authors:  W A Knaus; J E Zimmerman; D P Wagner; E A Draper; D E Lawrence
Journal:  Crit Care Med       Date:  1981-08       Impact factor: 7.598

8.  A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis.

Authors:  E L Bradley; K Allen
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

9.  Influence of levamisole on pancreatic infection in acute pancreatitis.

Authors:  A L Widdison; N D Karanjia; C Alvarez; H A Reber
Journal:  Am J Surg       Date:  1992-01       Impact factor: 2.565

10.  Early antibiotic treatment in acute necrotising pancreatitis.

Authors:  V Sainio; E Kemppainen; P Puolakkainen; M Taavitsainen; L Kivisaari; V Valtonen; R Haapiainen; T Schröder; E Kivilaakso
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

View more
  40 in total

Review 1.  Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis.

Authors:  Haim Shapiro; Pierre Singer; Zamir Halpern; Rafael Bruck
Journal:  Gut       Date:  2006-08-24       Impact factor: 23.059

2.  Vasoactive intestinal peptide promotes gut barrier function against severe acute pancreatitis.

Authors:  Lu Zhongkai; Ye Jianxin; Chen Weichang
Journal:  Mol Biol Rep       Date:  2011-07-03       Impact factor: 2.316

3.  Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia.

Authors:  Melissa J Puppa; James P White; Shuichi Sato; Mark Cairns; John W Baynes; James A Carson
Journal:  Biochim Biophys Acta       Date:  2011-09-02

Review 4.  Early phase of acute pancreatitis: Assessment and management.

Authors:  Veit Phillip; Jörg M Steiner; Hana Algül
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

5.  Association between acute pancreatitis and peptic ulcer disease.

Authors:  Kang-Moon Lee; Chang-Nyol Paik; Woo Chul Chung; Jin Mo Yang
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

6.  Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.

Authors:  Sakhawat H Rahman; Krishna V Menon; John H M Holmfield; Michael J McMahon; J Pierre Guillou
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

Review 7.  Timing of catheter drainage in infected necrotizing pancreatitis.

Authors:  Janneke van Grinsven; Hjalmar C van Santvoort; Marja A Boermeester; Cornelis H Dejong; Casper H van Eijck; Paul Fockens; Marc G Besselink
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-03-09       Impact factor: 46.802

8.  Impact of alanyl-glutamine dipeptide on severe acute pancreatitis in early stage.

Authors:  Ping Xue; Li-Hui Deng; Qing Xia; Zhao-Da Zhang; Wei-Ming Hu; Xiao-Nan Yang; Bing Song; Zong-Wen Huang
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

9.  Influence of Salvia miltiorrhizae on the mesenteric lymph node of rats with severe acute pancreatitis or obstructive jaundice.

Authors:  Zhang Xiping; Zhang Jie; Ye Shuyun; Wang Qili; Feng Guanghua; Pan Yan
Journal:  Mediators Inflamm       Date:  2010-02-15       Impact factor: 4.711

Review 10.  Prevention, detection, and management of infected necrosis in severe acute pancreatitis.

Authors:  Olaf J Bakker; Hjalmar C van Santvoort; Marc G H Besselink; Erwin van der Harst; H Sijbrand Hofker; Hein G Gooszen
Journal:  Curr Gastroenterol Rep       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.